Armistice Capital, LLC 2seventy Bio, Inc. Transaction History

Armistice Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$12.56 - $17.54 $4.22 Million - $5.89 Million	-336,000 Reduced 21.0%	1,264,000 $18.4 Million
Q2 2022 Aug 15, 2022	SELL	$10.55 - $18.81 $4.22 Million - $7.52 Million	-400,000 Reduced 20.0%	1,600,000 $21.1 Million
Q1 2022 May 16, 2022	BUY	$11.67 - $26.72 $13.4 Million - $30.6 Million	1,144,000 Added 133.64%	2,000,000 $34.1 Million
Q4 2021 Feb 14, 2022	BUY	$13.77 - $42.56 $11.8 Million - $36.4 Million	856,000 New	856,000 $21.9 Million

126

45.6M

122K

19.8K

Ticker TSVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,873,600
Market Cap $140M
Description
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.